1414-CD23 Regulation of NKT17 Homeostasis

This study identifies CD23 as a critical internal regulator that maintains the balance of NKT17 cells by protecting their survival. Researchers discovered that a lack of CD23 selectively reduces the number of these specific immune cells and decreases their IL-17 production, which in turn lowers airway inflammation in asthmatic models. Mechanistically, CD23 supports the IL-7Rα-mTORC2-AKT signaling pathway to prevent cell death and sustain metabolic health. While deficiency in this protein impairs the development of the NKT17 subset, the introduction of exogenous IL-7 can successfully restore cell frequency and function. Ultimately, the findings position the CD23-IL-7Rα-mTORC2 axis as a vital checkpoint for preserving NKT17 viability. These insights suggest that targeting this specific pathway could offer new therapeutic strategies for managing IL-17-mediated inflammatory diseases, such as allergic asthma.References:Niu L, Tan B, Xu J, et al. CD23 sustains NKT17 cell homeostasis via IL-7Rα-mTORC2 signaling[J]. Cell Death & Disease, 2026.前往小宇宙评论区与主播互动